文献速递其他结缔组织病血管炎

通过聚类分析识别原发性抗磷脂综合征高危特征:法国多中心队列研究

Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study.
PubMed 文献 · RMD Open · 2023-01-01

该法国多中心队列研究纳入2012年1月至2019年1月间持续抗磷脂抗体阳性、排除系统性红斑狼疮等系统性自身免疫病的患者,采用混合数据因子分析坐标的层次聚类分析,识别出4个聚类,其中第4类为「高危APS」,包含更年轻、三抗体阳性、抗核抗体阳性、非标准表现及动脉事件更频繁的患者;无症状aPL携带者复发少于其他聚类,但各聚类间复发率或死亡无其他差异。

要点

  • 研究识别4个聚类:无症状aPL携带者、男性血栓表型、女性产科表型、高危APS。
  • 高危APS聚类以更年轻、三抗体阳性、抗核抗体、非标准表现及动脉事件更频繁为特征。
  • 无症状aPL携带者复发少于其他聚类,但聚类间复发率或死亡无其他差异。

核心结论

  • 在原发性APS患者中识别出4个聚类,其中之一为「高危APS」。
  • 基于聚类的治疗策略应在未来前瞻性研究中探索。

研究设计与样本

  • 法国多中心队列研究,纳入2012年1月至2019年1月间测得的持续APS抗体(悉尼标准)患者。
  • 排除系统性红斑狼疮或其他系统性自身免疫病患者。
  • 对基线患者特征采用混合数据因子分析坐标结果进行层次聚类分析以生成聚类。

主要发现

  • 聚类1为「无症状aPL携带者」,随访期间事件风险低。
  • 聚类2为「男性血栓表型」,患者年龄更大且静脉血栓栓塞事件更多。
  • 聚类3为「女性产科表型」,伴有产科和血栓事件。
  • 聚类4为「高危APS」,包括更年轻、三抗体阳性、抗核抗体、非标准表现及动脉事件更频繁的患者。
  • 生存分析显示无症状aPL携带者复发少于其他聚类,但聚类间复发率或死亡无其他差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Antiphospholipid syndrome (APS) is an autoimmune disease characterised by thrombosis (arterial, venous or small vessel) or obstetrical events and persistent antiphospholipid antibodies (aPL), according to the Sydney classification criteria. Many studies have performed cluster analyses among patients with primary APS and associated autoimmune disease, but none has focused solely on primary APS. We aimed to perform a cluster analysis among patients with primary APS and asymptomatic aPL carriers without any autoimmune disease, to assess prognostic value. METHODS: In this multicentre French cohort study, we included all patients with persistent APS antibodies (Sydney criteria) measured between January 2012 and January 2019. We excluded all patients with systemic lupus erythematosus or other systemic autoimmune diseases. We performed hierarchical cluster analysis on the factor analysis of mixed data coordinates results with baseline patient characteristics to generate clusters. RESULTS: We identified four clusters: cluster 1, comprising 'asymptomatic aPL carriers', with low risk of events during follow-up; cluster 2, the 'male thrombotic phenotype', with older patients and more venous thromboembolic events; cluster 3, the 'female obstetrical phenotype', with obstetrical and thrombotic events; and cluster 4, 'high-risk APS', which included younger patients with more frequent triple positivity, antinuclear antibodies, non-criteria manifestations and arterial events. Regarding survival analyses, asymptomatic aPL carriers relapsed less frequently than the others, but no other differences in terms of relapse rates or deaths were found between clusters. CONCLUSIONS: We identified four clusters among patients with primary APS, one of which was 'high-risk APS'. Clustering-based treatment strategies should be explored in future prospective studies.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Guedon AF, Ricard L, Laurent C, et al. Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study. RMD Open. 2023. PMID: 36894193. doi:10.1136/rmdopen-2022-002881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。